The clinical efficacy of first generation carcinoembryonic antigen (CEACAM5) specific CAR T cells is limited by poor persistence and transient pre-conditioning dependent respiratory toxicity

Fiona Thistlethwaite, David Gilham, Ryan Guest, Dominic Rothwell, Manon Pillai, Deborah Burt, Andrea J Byatte, Natalia Kirillova, Juan Valle, Surinder K Sharma , Kerry A. Chester, Nigel Westwood, Sarah ER Halford, Stephen Nabarro, Susan Wan, Eric Austin, Robert E Hawkins